
Keck School of Medicine of USC
We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.
I SPY 2.2: Responsive, Adaptive Trial to Prioritize Promising Investigational Agents in Stage II/III BC When They Matter Most
By
Keck School of Medicine of USC
FEATURING
Laura Esserman
By
Keck School of Medicine of USC
FEATURING
Laura Esserman
Comments 1
Login to view comments.
Click here to Login